MarketsStocksVIVANZA
VI

Vivanza Biosciences Ltd

NSE: VIVANZABSE: 530057Healthcare
Download Research Report7-page PDF
1.80
+0.00%
NSE · auto-updates while market open
Mkt Cap
₹1 Cr
P / E
1.8
P / B
0.2
ROE
9.4%
52W High
₹2.72
52W Low
₹1.65
Key Metrics
Market Cap
₹1 Cr
P / E
1.79
P / B
0.17
EV / EBITDA
-
ROCE
6.0%
ROE
9.4%
Debt / Equity
2.34
Book Value
₹10.90
EPS
₹0.10
Div Yield
0.0%
Face Value
-
Promoter Holding
20.0%
Revenue · ₹ Cr
10
FY20
10
FY21
10
FY22
18
FY23
28
FY24
7
FY25
116
FY26
Net Profit · ₹ Cr
0
0
1
1
0
0
-1
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹0.2
₹0.8
₹1.5
₹0.1
₹0.1
₹-1.1
₹-0.5
FY19FY20FY21FY22FY23FY24FY26
Q1 2026 snapshot
Sales
₹6 Cr
Operating profit
-
OPM
-
Net profit
₹-0 Cr
EPS
-
Scorecard · 7 axes
Quality
Avg
52/100
Valuation
Strong
1.8×
Growth
Strong
+67.2%
Profitability
Weak
7.7%
Performance
Bad
-24.1%
Entry Point
Good
66%
Red Flags
Avg
1 flag
Shareholding Pattern
20.0%Promoter
Promoter20.0%
Public80.0%
Quarterly Results · ₹ Cr
QuarterFY18 12QFY19 09Q
Revenue6,58,00094,000
Net Profit-0.262-0.306
NPM %-0.0%-0.0%
AlertPre-trade